Axsome Therapeutics
AXSM
AXSM
17 hedge funds and large institutions have $44.9M invested in Axsome Therapeutics in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
17
Holders Change
+6
Holders Change %
+54.55%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.79M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$13.6M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$114K |
4 |
4
Morgan Stanley
New York
|
$170K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$103K |